MENU
NKTR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Nektar Therapeutics (NKTR) Earnings Date & Reports

Nektar Therapeutics is a pharmaceutical company focused on the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

NKTR is expected to report earnings to fall 746.67% to -19 cents per share on May 08

Nektar Therapeutics NKTR Stock Earnings Reports
Q1'25
Est.
$-0.19
Q4'24
Beat
by $0.19
Q3'24
Beat
by $0.02
Q2'24
Missed
by $0.06
Q1'24
Missed
by $0.04
The last earnings report on March 12 showed earnings per share of 2 cents, beating the estimate of -15 cents. With 3.74M shares outstanding, the current market capitalization sits at 111.76M.
View a ticker or compare two or three
NKTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of inhalation drug delivery systems

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
455 Mission Bay Boulevard South
Phone
+1 415 482-5300
Employees
137
Web
https://www.nektar.com